Antimicrobial Agents and Chemotherapy, August 2004, p. 3175-3178, Vol. 48, No. 8
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.8.3175-3178.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Rv2686c-Rv2687c-Rv2688c, an ABC Fluoroquinolone Efflux Pump in Mycobacterium tuberculosis
Maria Rosalia Pasca, Paola Guglierame, Fabio Arcesi, Marco Bellinzoni, Edda De Rossi, and Giovanna Riccardi*
Department of Genetics and Microbiology, University of Pavia, 27100 Pavia, Italy
Received 22 December 2003/
Returned for modification 14 March 2004/
Accepted 23 April 2004
The Mycobacterium tuberculosis Rv2686c-Rv2687c-Rv2688c operon, encoding an ABC transporter, conferred resistance to ciprofloxacin and, to a lesser extent, norfloxacin, moxifloxacin, and sparfloxacin to Mycobacterium smegmatis. The resistance level decreased in the presence of the efflux pump inhibitors reserpine, carbonyl cyanide m-chlorophenylhydrazone, and verapamil. Energy-dependent efflux of ciprofloxacin from M. smegmatis cells containing the Rv2686c-Rv2687c-Rv2688c operon was observed.
* Corresponding author. Mailing address: Department of Genetics and Microbiology, University of Pavia, Via Ferrata 1, 27100 Pavia, Italy. Phone: 39 0382 505574. Fax: 39 0382 528496. E-mail: riccardi{at}ipvgen.unipv.it.
Antimicrobial Agents and Chemotherapy, August 2004, p. 3175-3178, Vol. 48, No. 8
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.8.3175-3178.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Roback, P., Beard, J., Baumann, D., Gille, C., Henry, K., Krohn, S., Wiste, H., Voskuil, M.I., Rainville, C., Rutherford, R.
(2007). A predicted operon map for Mycobacterium tuberculosis. Nucleic Acids Res
35: 5085-5095
[Abstract]
[Full Text]
-
Shandil, R. K., Jayaram, R., Kaur, P., Gaonkar, S., Suresh, B. L., Mahesh, B. N., Jayashree, R., Nandi, V., Bharath, S., Balasubramanian, V.
(2007). Moxifloxacin, Ofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis: Evaluation of In Vitro and Pharmacodynamic Indices That Best Predict In Vivo Efficacy. Antimicrob. Agents Chemother.
51: 576-582
[Abstract]
[Full Text]
-
Riordan, J. T., Muthaiyan, A., Van Voorhies, W., Price, C. T., Graham, J. E., Wilkinson, B. J., Gustafson, J. E.
(2007). Response of Staphylococcus aureus to Salicylate Challenge. J. Bacteriol.
189: 220-227
[Abstract]
[Full Text]
-
Piddock, L. J. V.
(2006). Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria. Clin. Microbiol. Rev.
19: 382-402
[Abstract]
[Full Text]
-
Bernard, R., El Ghachi, M., Mengin-Lecreulx, D., Chippaux, M., Denizot, F.
(2005). BcrC from Bacillus subtilis Acts as an Undecaprenyl Pyrophosphate Phosphatase in Bacitracin Resistance. J. Biol. Chem.
280: 28852-28857
[Abstract]
[Full Text]
-
Poole, K.
(2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother
56: 20-51
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.